Second Opinion Icon

Will "Ozempic penis" lead patients to risky peptides?

Learn More

‘Horny peptides’ go mainstream: Here’s what patients may get wrong

By Alpana Mohta, MD, DNB, FEADV, FIADVL, IFAADFact-checked by Davi ShermanPublished August 31, 2026


Industry Buzz

Peptides can certainly play a role in modern medicine. However, reasonable use begins where experimentation using products obtained through online vendors ceases.

—Kyle Hoedebecke, MD

A peptide developed from the melanocortin pathway ended up becoming a prescription treatment for low sexual desire. Now, PT-141 is having a second life online. 

Bremelanotide, or PT-141, is a synthetic analogue of α-melanocyte-stimulating hormone that activates melanocortin receptors, particularly MC4R, in the central nervous system. Early studies showed that melanocortin signaling could influence sexual behavior and erectile activity, leading researchers to investigate PT-141 as a treatment for sexual dysfunction. 

The drug received FDA approval in 2019 for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.[] Its mechanism is also unusual for sexual medicine. In the two phase 3 RECONNECT trials, 1,267 women were randomized. Bremelanotide produced statistically significant increases in sexual desire and reductions in distress related to low desire vs placebo.[]

Robert Thompson, DO, MS, CPE, FAAFP, says, “Bremelanotide has been FDA-approved for use in premenopausal women with acquired generalized hypoactive sexual desire disorders. In contrast to drugs such as sildenafil that work primarily by increasing blood flow to the genitals, and those [such as] testosterone that are hormone replacements that replace deficient hormones, bremelanotide works on pathways in the central nervous system related to melanocortins.”

Related: Could 'rebranding' vaccines as peptides boost immunization rates—or backfire?

There is limited evidence in men

Bremelanotide has been studied in men with erectile dysfunction, including men who did not respond to sildenafil. A randomized trial involving 342 married men ages 28–59 years found improved erectile responses with intranasal bremelanotide.

But the FDA has not approved use for men. James Lyons, MD, a family medicine physician, describes the evidence as promising but still experimental. “Bremelanotide is not a general libido-enhancing agent. Bremelanotide is not FDA-approved for men [or] postmenopausal women or simply to enhance sexual performance.”

The 'Barbie drug' link

The “Barbie drug” nickname belongs primarily to Melanotan II, an unapproved α-MSH analogue marketed for tanning.[] Melanotan II also activates MC4R and has sexual effects, which explains some overlap between the online tanning and libido-enhancing markets. A 2024 systematic review found that social media played a major role in promoting unlicensed Melanotan products. 

But the science is now colliding with a much broader peptide market. PT-141 is being discussed on social media and online forums alongside experimental compounds, compounded preparations, and peptides marketed for sexual enhancement. 

Related: Everything doctors need to know about the ‘peptide Wild West’

Patients are asking whether PT-141 and Melanotan II are interchangeable, which one is better for libido, and whether both are needed. 

In a Reddit thread, one user wrote, “Melanotan contains or turns into PT 141. I'm not sure which. I just know it’s pointless to take both.” Another responded, “That’s not true they are just both in the same category. Pt141 is better for a stronger libido and erection. Melanotan is better for tanning and also has an effect on libido it’s just not as strong.”

In another Reddit thread, a patient who developed an unexpected tan after using a product sold as PT-141 wrote, “Now I question whether I was sold pt141 or melatonan, which is also good for ED.”

Inside the growing, unregulated peptide market

Bremelanotide itself is not an over-the-counter drug. However, a growing online and offline peptide market sells PT-141 separately from the FDA-approved product, often as a research chemical or compounded preparation. Physician Kyle Hoedebecke, MD, says, “There is a considerable difference between FDA-approved bremelanotide and PT-141 obtained online from a peptide vendor.” 

The San Francisco Standard reports that Bay Area clinics were offering PT-141 for sexual health, including a clinic selling a combination called “Thrill Pill” containing PT-141, oxytocin, and Cialis.[] Another reportedly marketed PT-141 alongside Kisspeptin-10 and Melanotan II for “wellness and libido restoration.”

Related: Trump taps another wellness influencer for top HHS role: Docs warn of expanded access to peptides, controversial therapies

As of August 15, 2026, Finnrick has published 117 independent lab tests of PT-141 from 32 vendors: 72 passed, 43 failed, and 2 were not classifiable (incomplete data) under the default public standard, Purity Focus (HPLC purity of at least 99.5%, fill within ±35% of the label claim).[]

“Bremelanotide has an identified active ingredient, a standard dose, an established safety profile, and [it] is manufactured according to FDA standards. Research-grade peptides intended for laboratory use are not equivalent to medications designed for administration in humans, so I do not think that research-grade peptides should automatically be considered acceptable replacements based solely upon their having the same molecular name,” Dr. Hoedebecke notes.

“Similarly, compounded preparations require careful selection of sources and monitoring of patients’ responses, since quality control is at least as important as pharmacological considerations,” he adds.

In the clinic: Patient counseling points

Dr. Hoedebecke suggests the following counseling points: “I am willing to engage with a patient’s interest in peptides. First, I want to understand the underlying reasons for the sexual problem(s), assess potential cardiovascular risks, evaluate current medications for the patient, address limitations of available data related to the treatment outside of the approved population, and verify that the product is either pharmaceutical or clinical-grade.”

“Peptides can certainly play a role in modern medicine. However, reasonable use begins where experimentation using products obtained through online vendors ceases,” he adds.


SHARE THIS ARTICLE

ADVERTISEMENT